China SXT Pharmaceuticals Inc. Announces $9 Million Registered Direct Offering
China SXT Pharmaceuticals announced a $9 million registered direct offering, selling 4.5 million units at a purchase price of $2.00 per unit. Each unit consists of one Class A ordinary share and one common warrant exercisable at $3.20 per share, with the warrants expiring one year after issuance.
Key figures
- Deal Value Usd
- 9000000
- Offering Price
- 2
- Shares Offered
- 4500000
- Warrants per unit
- 1
- Warrant exercise price
- 3.2
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.